Change in Boardroom
| PHARMANIAGA BERHAD |
| Date of change | 31 Mar 2020 |
| Name | DATO' FARSHILA BINTI EMRAN |
| Age | 54 |
| Gender | Female |
| Nationality | Malaysia |
| Designation | Managing Director |
| Directorate | Executive |
| Type of change | Others |
| Description | Completion of service contract |
Qualifications
| No | Qualifications |
Major/Field of Study |
Institute/University |
Additional Information |
|
Masters
|
• Master of Business Administration |
Universiti Utara Malaysia |
|
|
|
Diploma
|
Office Management |
Universiti Teknologi MARA |
|
| Working experience and occupation | Dato Farshila began her career as a tutor in Universiti Teknologi MARA before she became the Assistant Representative of SEVES Sediver France, a French public listed high voltage transmission equipment company in Malaysia, in 1990. Then she was promoted as the Malaysian Representative of the successful company until 2001. Within the same year, she established Idaman Pharma Sdn Bhd and started her venture in the highly regulated pharmaceutical industry. In 2005, she took a bold step by taking over a pharmaceutical plant in Sungai Petani, Kedah and established Idaman Pharma Manufacturing Sdn Bhd (IPMSB). Subsequently, she acquired another plant in Seri Iskandar, Perak. Under her leadership, IPMSB developed a synergistic partnership with Boustead Holdings Berhad (Boustead) and facilitated the acquisition of Pharmaniaga Berhad by Boustead in 2011. Dato Farshila was subsequently appointed as the Managing Director of Pharmaniaga Berhad and since then, she has successfully enhanced the value of the Company. |
| Family relationship with any director and/or major shareholder of the listed issuer | NIL |
| Any conflict of interests that he/she has with the listed issuer | NIL |
| Details of any interest in the securities of the listed issuer or its subsidiaries | 458,700 ordinary shares in Pharmaniaga Berhad |
| Remarks : |
- |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 21 Jan 2020 |
| Category | Change in Boardroom |
| Reference Number | C03-21012020-00008 |